Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2.
about
Inhibition of Farnesyltransferase Potentiates NOTCH-Targeted Therapy against Glioblastoma Stem Cells.Epigenetic regulation of cancer progression by EZH2: from biological insights to therapeutic potential.Destabilizing NEK2 overcomes resistance to proteasome inhibition in multiple myeloma.The developmental origin of brain tumours: a cellular and molecular framework.Apoptotic Cell-Derived Extracellular Vesicles Promote Malignancy of Glioblastoma Via Intercellular Transfer of Splicing Factors.
P2860
Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Targeting NEK2 attenuates glio ...... istone methyltransferase EZH2.
@en
type
label
Targeting NEK2 attenuates glio ...... istone methyltransferase EZH2.
@en
prefLabel
Targeting NEK2 attenuates glio ...... istone methyltransferase EZH2.
@en
P2093
P2860
P356
P1476
Targeting NEK2 attenuates glio ...... histone methyltransferase EZH2
@en
P2093
Ahmed Mohyeldin
Brendan Frett
Do-Hyun Nam
Dongquan Chen
Harley I Kornblum
Ichiro Nakano
Maode Wang
P2860
P304
P356
10.1172/JCI89092
P407
P50
P577
2017-07-24T00:00:00Z